Mirum Pharmaceuticals, Inc.
DE ˙ DB ˙ US6047491013
76,16 € ↓ -0,96 (-1,24%)
2026-06-04
AKTIENPREIS
SecurityDE:08D / Mirum Pharmaceuticals, Inc.
InstitutionComerica Bank
Latest Disclosed Ownership675 shares
Latest Disclosed Value $ 53,332
Comerica Bank reports 8.54% decrease in ownership of 08D / Mirum Pharmaceuticals, Inc.

On January 29, 2026 - Comerica Bank filed a 13F-HR form disclosing ownership of 675 shares of Mirum Pharmaceuticals, Inc. (DE:08D) valued at $44,888 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 738 shares of Mirum Pharmaceuticals, Inc.. This represents a change in shares of -8.54% during the quarter. The current value of the position is $51,408 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 675 -63 -8.54 53 -1.85 0.0002
2025-11-14 2025-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 738 -29 -3.78 54 38.46 0.0002
2025-08-14 2025-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 767 -128 -14.30 39 -2.50 0.0002
2025-05-14 2025-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 895 278 45.06 40 60.00 0.0002
2025-02-14 2024-12-31 13F/A-1 MIRUM PHARMACEUTICALS COM 604749101 617 29 4.93 26 13.64 0.0001
2025-02-14 2024-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 617 29 26 0.0001
2024-11-14 2024-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 588 426 262.96 23 340.00 0.0001
2024-08-15 2024-06-30 13F MIRUM PHARMACEUTICALS INC COM COMMON 604749101 162 62 62.00 6 150.00 0.0000
2024-05-16 2024-03-31 13F MIRUM PHARMACEUTICALS INC COM COMMON 604749101 100 5 5.26 2 0.00 0.0000
2024-02-14 2023-12-31 13F MIRUM PHARMACEUTICALS INC COM COMMON 604749101 95 95 3 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.